Business
GB Sciences Expands into the Oklahoma Medical Cannabis Market
GB Sciences Expands into the Oklahoma Medical Cannabis Market.
About this update from Gb Sciences, Inc.
[{"type":"text","content":"\n\n\n\nGB Sciences Expands into the Oklahoma Medical Cannabis Market\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nGB Sciences Expands into the Oklahoma Medical Cannabis Market\nCanada NewsWire\nLAS VEGAS, Nov. 14, 2018\n\n\n\nGB Sciences' signs a letter of binding agreement with 4EVERGRN in its first out-of-state licensing deal.  \n LAS VEGAS, Nov. 14, 2018 /CNW/ -- GB Sciences, Inc. (OTCQB: GBLX) is proud to announce that it has signed a binding letter of intent with 4EVERGRN, LLC in Oklahoma.  This company has been awarded cultivation, processing and dispensary licenses by the Oklahoma Medical Marijuana Authority.\n\n\nUnder their agreement, GB Sciences will design a cultivation and processing facility in Oklahoma, and provide 4EVERGRN with best-practice operating procedures. 4EVERGRN will produce and distribute GB Sciences products and brands under a licensing agreement in exchange for a royalty to GB Sciences.  The agreement can be terminated if quality standards are abridged or compromised.\nMonica Poss, VP of Corporate Planning, GB Sciences, remarks: \"We are very excited to have penned our first licensing deal and hope it serves as a template for further agreements. These will allow GB Sciences to expand its reach nationwide without extensive capital outlays. Our partners in Oklahoma, Brooklyn Green Clopton and her associates at 4EVERGRN, are serious and professional in their efforts to bring the advantages of medical cannabis to the people of the state of Oklahoma.  We are proud to be partnered with them.\"\nBrooklyn Green Clopton, CEO of 4EVERGRN, responds: \"Our 4EVERGRN team is comprised of Oklahomans that are passionate about cutting-edge cannabis development. 4EVERGRN's Dr. JoAnn Ryan has led the charge to ensure we create the best pharmaceutical grade cannabis products for the patients of Oklahoma. We believe GB Sciences' tissue culture propagation will lead the industry with the safest and most consistent products and 4EVERGRN is excited to be partnered with them in Oklahoma's new medical marijuana market.\" \nJohn Poss, C...